NCT02600793View on ClinicalTrials.gov

Ceftaroline Diffusion Into Cerebrospinal Fluid of Children

PHASE1UnknownINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Cerebrospinal Fluid ShuntsVentriculoperitoneal Shunt

Interventions

DRUG

Ceftaroline

Following Ceftaroline single IV dose, 3 blood and cerbrospinal fluid samples will be collected

Trial Locations (1)

48201

RECRUITING

Children's Hospital of Michigan, Detroit

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Basim Asmar

OTHER